Is the Etoposide, Doxorubicin, and Cisplatin Plus Mitotane Regimen Able to Prolong Survival in Patients With Metastatic Adrenocortical Carcinoma?

Endocrine Practice · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles